Oncogenic forms of p21ras are found in a wide range of human tumours. However, the mechanism by which p21ras transforms remains obscure. Genetic evidence has identified a domain of p21ras that is involved with interaction with an effector molecule required for transformation. Two proteins, GAP and the tumour suppressor NF1, interact with p21ras in this region but it is an unresolved puzzle whether either of these is the effector. After interaction with an effector, two downstream events-activation of protein kinase C and another pathway-are necessary for induction of DNA synthesis by oncogenic p21ras; however, morphological transformation does not require activation of protein kinase C.